Atrophy Clinical Trial
Official title:
Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
This study will quantify and examine the extent to which the quadriceps femoris muscle group atrophies following tibial plateau fractures and the length of time that atrophy affects function. The study will also look at the effects of tibial plateau fractures on the quadriceps muscle and the effect this atrophy has on functional outcome. Quadriceps atrophy will be measured both clinically and by using MRI scans taken pre-operatively, 3 months post operatively, and 1 year post-operatively. The injured leg and the non-injured leg will be scanned in order for the non-injured leg to serve as the control. In this way muscle volume can be estimated from the muscle thickness at specific locations in the thigh. The muscle strength of the quadriceps will also be assessed at the 3 month and 1 year visit by measuring isokinetic knee-extension torque, and functional assessment questionnaires will be completed at each study visit.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02497547 -
An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
|
Phase 2 | |
| Completed |
NCT02332343 -
Sparing of the Fovea in Geographic Atrophy Progression
|
N/A | |
| Completed |
NCT00566982 -
A Clinical Study to Evaluate the Safety of Ospemifene
|
Phase 3 | |
| Completed |
NCT01586364 -
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
|
Phase 3 | |
| Active, not recruiting |
NCT05698316 -
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression
|
||
| Recruiting |
NCT05869812 -
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
|
Phase 2 | |
| Completed |
NCT02770365 -
Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
|
Phase 3 | |
| Completed |
NCT02747641 -
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
|
N/A | |
| Recruiting |
NCT02137824 -
A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients
|
N/A | |
| Completed |
NCT01585558 -
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
|
Phase 3 | |
| Completed |
NCT02868749 -
Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue
|
N/A | |
| Recruiting |
NCT01911312 -
Evaluation of Thermal-Aided Muscle Stimulation
|
N/A | |
| Completed |
NCT00729469 -
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
|
Phase 3 | |
| Completed |
NCT01553773 -
Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
|
Phase 2 | |
| Recruiting |
NCT02745366 -
Buccal Fat Pad Derived Stem Cells With Cortical Tenting in Posterior Mandible Reconstruction
|
Phase 1 | |
| Completed |
NCT00744094 -
Resistance Training in Elderly
|
Phase 1/Phase 2 | |
| Completed |
NCT00807508 -
Leucine Supplementation in Elderly Men
|
Phase 1/Phase 2 | |
| Completed |
NCT00276094 -
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 | |
| Terminated |
NCT00267839 -
Effect of Exercise on Risk-factors of Elderly Women
|
Phase 3 | |
| Terminated |
NCT00292916 -
Effect of Whole Body Vibration on Bone and Fall Related Parameters
|
Phase 3 |